Examine This Report on sodium pentobarbital sds
Examine This Report on sodium pentobarbital sds
Blog Article
Drug interactions: Most studies of clinically important drug interactions transpiring with the barbiturates have included phenobarbital.
pentobarbital will lower the extent or effect of conjugated estrogens by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
pentobarbital will lower the extent or effect of exemestane by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. For sufferers obtaining exemestane with a powerful CYP3A4 inducer the proposed dose of exemestane is fifty mg every day after a food.
benzhydrocodone/acetaminophen and pentobarbital both equally raise sedation. Stay clear of or Use Alternate Drug. Restrict use to patients for whom alternative procedure solutions are inadequate
pentobarbital will reduce the extent or effect of pimavanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on. Stay away from coadministration if at all possible. Keep an eye on for decreased pimavanserin efficacy. An increase in pimavanserin dosage may be essential.
pentobarbital will lower the level or effect of armodafinil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Not known.
pentobarbital will more info decrease the extent or effect of levonorgestrel oral/ethinylestradiol/ferrous bisglycinate by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Carefully. The efficacy of hormonal contraceptives might be lowered.
Nursing mothers: Warning needs to be exercised whenever a barbiturate is administered into a nursing lady given that little amounts of barbiturates are excreted from the milk.
pentobarbital will minimize the extent or effect of voriconazole by influencing hepatic enzyme CYP2C9/ten metabolism. Insignificant/Significance Unknown.
pentobarbital will lower the level or effect of loratadine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
pentobarbital will lower the extent or effect of venetoclax by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will boost the stage or effect of ivosidenib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Coadministration of ivosidenib with robust CYP3A4 inducers lowered ivosidenib plasma concentrations.
pentobarbital will lower the extent or effect of acalabrutinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
pentobarbital decreases amounts of ponatinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Stay clear of or Use Alternate Drug. Avoid unless the coadministration outweighs the possible hazard of ponatinib underexposure; monitor for indications of diminished efficacy.